23andMe Holding Co. (MEHCQ)
OTCMKTS
· Delayed Price · Currency is USD
4.780
-0.120 (-2.45%)
Jul 7, 2025, 9:30 AM EDT
23andMe Holding Co. Revenue
In the fiscal year ending March 31, 2025, 23andMe Holding Co. had annual revenue of $189.90M, down -13.54%. 23andMe Holding Co. had revenue of $45.15M in the quarter ending March 31, 2025, a decrease of -29.49%.
Revenue
189.90M
Revenue Growth
-13.54%
P/S Ratio
0.71
Revenue / Employee
727.57K
Employees
265
Market Cap
134.95M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Elite Pharmaceuticals | 84.04M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 215.62M |
American Oncology Network | 1.76B |
Northwest Biotherapeutics | 1.47M |
Silence Therapeutics | 27.70M |
23andMe Holding Co. News
- 7 days ago - 23andMe Receives Court Approval for Sale to TTAM Research Institute, a Nonprofit Public Benefit Corporation - GlobeNewsWire
- 16 days ago - The Score: 23andMe, U.S. Steel, Accenture and More Stocks That Defined the Week - WSJ
- 19 days ago - UK Watchdogs Fine 23andMe $3.1M for Data Security Violations - CNET
- 19 days ago - UK Watchdogs Fines 23andMe $3.1 million For Data Security Violations - CNET
- 20 days ago - 23andMe fined millions by UK watchdog over 'profoundly damaging' cyber attack - Skynews
- 20 days ago - DNA testing firm 23andMe fined £2.3m by UK regulator for 2023 data hack - The Guardian
- 20 days ago - Regeneron declines to make higher bid for 23andMe after Wojcicki's $305 million offer - Reuters
- 20 days ago - 23andMe co-founder Anne Wojcicki regains control of bankrupt genetic testing company - Fox Business